Leadership Overview
Advarra has 5 executives leading key functions including strategy, operations, finance, technology, and revenue.
Driven by a commitment to advancing clinical research, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance, making trials safer, smarter, and faster.
Driven by a commitment to advancing clinical research, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance, making trials safer, smarter, and faster.
Leadership Roles at Advarra
Gadi Saarony - Chief Executive Officer
Gadi Saarony, the Chief Executive Officer at Advarra, directs the overarching strategy and vision for the organization. Saarony guides Advarra's mission to advance clinical research by fostering collaboration among life sciences companies, CROs, research sites, investigators, and academia. This leadership role involves ensuring Advarra's integrated solutions effectively safeguard trial participants, empower clinical sites, and optimize research performance. By focusing on safety, technology, and collaboration, Saarony drives the company's commitment to making clinical trials safer, smarter, and faster. The Chief Executive Officer's strategic direction ensures Advarra maintains its position at the forefront of the industry, adapting to evolving research landscapes and client needs. Gadi Saarony's executive oversight is critical to achieving the company's growth objectives and enhancing its market impact across the global research ecosystem.
Dwight Van Inwegen - Chief Financial Officer
Dwight Van Inwegen, the Chief Financial Officer at Advarra, directs all financial operations and strategic financial planning for the organization. Van Inwegen manages Advarra's fiscal health, overseeing budgeting, forecasting, and financial reporting to support the company's growth and operational objectives. This financial leadership ensures Advarra has the resources to invest in innovative technologies and expand its integrated solutions that advance clinical research. By maintaining robust financial controls, Dwight Van Inwegen supports the company's mission to make trials safer, smarter, and faster. The Chief Financial Officer's role is crucial in guiding Advarra's financial strategy, including capital allocation and risk management, to sustain long-term success. Van Inwegen's expertise is vital for Advarra's continued expansion and its ability to deliver value to stakeholders in the life sciences sector.

Scott Uebele - Chief Operating Officer
Scott Uebele, the Chief Operating Officer at Advarra, oversees the day-to-day operational execution and efficiency across the organization. Uebele manages the integration of Advarra's diverse offerings, including trusted review solutions, innovative technologies, and consulting services, to ensure seamless delivery to clients. This operational leadership focuses on optimizing internal processes to enhance research performance and ensure compliance for clinical trials. By driving operational excellence, Scott Uebele supports the company's goal of making research safer, smarter, and faster. The Chief Operating Officer's responsibilities extend to managing resource allocation and ensuring that Advarra's infrastructure effectively supports its mission of advancing clinical research. Uebele's strategic management of operations is fundamental to maintaining high standards of service and client satisfaction across all industry segments Advarra serves.
Jeff Sidell - Chief Technology Officer
Jeff Sidell, the Chief Technology Officer at Advarra, leads the strategic development and implementation of technology solutions that underpin Advarra's mission. Sidell oversees the innovation and integration of technological platforms designed to enhance clinical trial safety, efficiency, and collaboration. This technology leadership ensures Advarra's offerings, from review solutions to data management, are cutting-edge and effectively support research sites and life sciences companies. By driving technological advancement, Jeff Sidell contributes directly to making clinical trials safer, smarter, and faster. The Chief Technology Officer's responsibilities include managing the company's technology infrastructure, cybersecurity, and the development of new digital tools that empower clinical research. Sidell's vision for technology is integral to Advarra's competitive edge and its ability to adapt to the digital transformation in research.

Allie Rozanski - Chief Revenue Officer & Client Executive
Allie Rozanski, the Chief Revenue Officer & Client Executive at Advarra, drives revenue growth and manages key client relationships across the organization. Rozanski leads the commercial strategy, focusing on expanding Advarra's market reach and ensuring client success with its integrated research solutions. This revenue leadership role is critical for fostering partnerships with life sciences companies, CROs, and research sites, aligning Advarra's services with their evolving needs. By optimizing revenue streams, Allie Rozanski supports the company's objective of making clinical trials safer, smarter, and faster. The Chief Revenue Officer & Client Executive's responsibilities include overseeing sales, business development, and client engagement to maximize value and drive adoption of Advarra's innovative technologies. Rozanski's client-centric approach is fundamental to Advarra's sustained growth and industry leadership.
Explore Leadership Teams in Business Services
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase
Company Leadership JM
JD

FO
Founded in 2004, Broad Institute researches biology and new treatments for human diseases by using genomics to find new therapies. They are located in Cambridge, Massachusetts.
Company Leadership EL

Founded in 1984, the Jefferson Lab is headquartered in Newport News, Virginia. They conduct basic research of the atom's nucleus using the lab's unique particle accelerator, known as the Continuous Electron Beam Accelerator Facility (CEBAF).
Company Leadership
JH
BB
LH
Founded in 1996 and headquartered in Grand Rapids, Michiga, Van Andel Institute (VAI) is an independent nonprofit biomedical research and science education organization committed to improving the health and enhancing the lives of current and future generations.
Company Leadership DV
JN
TM
